In this Masterclass episode, host, Dr Harriette Van Spall’s guest is Dr Eugene Braunwald, Distinguished Hersey Professor of Medicine at Harvard Medical School and founding chairman of the TIMI Study Group.

In this in-depth discussion on neprilysin inhibition in patients with reduced LVEF, Dr Braunwald summarises the findings from the PARADISE-MI trial in the context of recent data and talks about how these results should impact our understanding of the neprilysin pathway in heart failure care. 

Recorded remotely from Hamilton and Boston, 2021. 

Editor: Mirjam Boros